ArticleCase reports in oncology

Metastatic SMARCB1-Deficient Renal Medullary Carcinoma without Hemoglobinopathy with Durable and Dramatic Response to Pembrolizumab plus Lenvatinib: Case Report.

William McCamy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.